Skip to main content

Several major healthcare systems are creating their own AI-driven chatbots to help clinicians more easily access and navigate patient health records.

Why Some Hospitals Are Developing Custom AI Chatbots for Patient Records

Scientists have developed an AI system that analyzes clinical notes to identify patients who may be at risk of cognitive decline, enabling healthcare providers to intervene earlier.

AI-Assisted Early Detection of Cognitive Decline in Patients

More than 60 healthcare organizations have jointly requested that national health record exchanges enhance protections to block unauthorized access to patient information by malicious parties.

Over 60 Hospitals Urge Stronger Security Measures for Patient Data Sharing

In this edition of AI Prognosis, we highlight the most significant health AI developments that have emerged in the past month, setting the stage for innovation and change in 2026.

Top 5 Health AI Developments to Watch as 2026 Begins

Bob Nelsen, a renowned venture capitalist, is spearheading a groundbreaking AI venture that he predicts will rank among the world's most influential companies. This secretive project, dubbed Prometheus, marks a significant expansion of Nelsen's interests beyond the healthcare sector, highlighting his confidence in artificial intelligence's transformative potential.

Venture Capitalist Bob Nelsen's New AI Initiative Extends Beyond Healthcare

AI chatbot developers are increasingly offering health advice directly to consumers. This shift raises important questions about the accuracy and safety of AI-generated medical guidance.

AI Chatbots Venture into Health Advice: Can You Rely on Them?

Artificial intelligence has reached a pivotal milestone by successfully creating drug-like antibodies, signaling a potential transformation in the biopharmaceutical industry. This breakthrough prompts the question: how soon will AI-driven antibody design revolutionize drug development and biopharma practices?

AI Advances in Developing Drug-Like Antibodies: When Will Biopharma See a Breakthrough?

As 2026 approaches, the health care sector prepares for critical discussions on financing clinical AI. Industry stakeholders face important decisions about payment models that will shape the future of AI integration in medical treatment.

Who Will Fund AI in Health Care? Key Payment Trends to Monitor in 2026

Doctors are overwhelmed by the sheer volume of new medical research, making it difficult to stay fully informed. Meanwhile, patients are increasingly turning to AI tools for health insights. It's time for medical professionals to adopt AI as a valuable resource to enhance their practice and deliver better care.

Why Doctors Should Embrace AI in Patient Care

The FDA has granted approval for the oral formulation of Novo Nordisk’s Wegovy, originally an injectable treatment for weight management. This marks the first approval of a GLP-1 receptor agonist in pill form for obesity treatment, potentially broadening patient access to this therapy.

FDA Gives Green Light to Oral Version of Novo Nordisk’s Wegovy, Expanding Weight Loss Options